SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.
Phone: 02 9698 2022
TdB Labs polysaccharides
TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent...
Cayman Chemical Epigenetics Screening Library (96-Well)
The Cayman Chemical Epigenetics Screening Library (96-Well) is a compound library that is...
Cayman Chemical Kinase Screening Library (96-Well)
Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains...
